Amebiasis and 'nonpathogenic' intestinal protozoa

John Aucott, J. I. Ravdin

Research output: Contribution to journalArticle

Abstract

Infection with single or multiple species of intestinal protozoa is common in humans and can result in either asymptomatic colonization or symptoms of intestinal disease. Entamoeba histolytica serves as a paradigm for invasive colonic protozoal infection. The key to diagnosis and treatment of amebiasis is knowledge of the epidemiologic risk factors and clinical manifestations, a rational approach to diagnosis, and an understanding of the sites of action and uses of anti-amebic drugs. This knowledge of treatment provides a context for consideration of intestinal infection with less common protozoan pathogens such as Dientamoeba fragilis and Balantidium coli and 'nonpathogenic' protozoa such as Blastocystis hominis and Entamoeba coli.

Original languageEnglish (US)
Pages (from-to)467-485
Number of pages19
JournalInfectious Disease Clinics of North America
Volume7
Issue number3
StatePublished - 1993
Externally publishedYes

Fingerprint

Amoebic Dysentery
Dientamoeba
Balantidium
Infection
Blastocystis hominis
Epidemiologic Factors
Entamoeba
Amebiasis
Intestinal Diseases
Entamoeba histolytica
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Amebiasis and 'nonpathogenic' intestinal protozoa. / Aucott, John; Ravdin, J. I.

In: Infectious Disease Clinics of North America, Vol. 7, No. 3, 1993, p. 467-485.

Research output: Contribution to journalArticle

@article{0d722f70b7754aaba8eccbbfbb47b9fa,
title = "Amebiasis and 'nonpathogenic' intestinal protozoa",
abstract = "Infection with single or multiple species of intestinal protozoa is common in humans and can result in either asymptomatic colonization or symptoms of intestinal disease. Entamoeba histolytica serves as a paradigm for invasive colonic protozoal infection. The key to diagnosis and treatment of amebiasis is knowledge of the epidemiologic risk factors and clinical manifestations, a rational approach to diagnosis, and an understanding of the sites of action and uses of anti-amebic drugs. This knowledge of treatment provides a context for consideration of intestinal infection with less common protozoan pathogens such as Dientamoeba fragilis and Balantidium coli and 'nonpathogenic' protozoa such as Blastocystis hominis and Entamoeba coli.",
author = "John Aucott and Ravdin, {J. I.}",
year = "1993",
language = "English (US)",
volume = "7",
pages = "467--485",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Amebiasis and 'nonpathogenic' intestinal protozoa

AU - Aucott, John

AU - Ravdin, J. I.

PY - 1993

Y1 - 1993

N2 - Infection with single or multiple species of intestinal protozoa is common in humans and can result in either asymptomatic colonization or symptoms of intestinal disease. Entamoeba histolytica serves as a paradigm for invasive colonic protozoal infection. The key to diagnosis and treatment of amebiasis is knowledge of the epidemiologic risk factors and clinical manifestations, a rational approach to diagnosis, and an understanding of the sites of action and uses of anti-amebic drugs. This knowledge of treatment provides a context for consideration of intestinal infection with less common protozoan pathogens such as Dientamoeba fragilis and Balantidium coli and 'nonpathogenic' protozoa such as Blastocystis hominis and Entamoeba coli.

AB - Infection with single or multiple species of intestinal protozoa is common in humans and can result in either asymptomatic colonization or symptoms of intestinal disease. Entamoeba histolytica serves as a paradigm for invasive colonic protozoal infection. The key to diagnosis and treatment of amebiasis is knowledge of the epidemiologic risk factors and clinical manifestations, a rational approach to diagnosis, and an understanding of the sites of action and uses of anti-amebic drugs. This knowledge of treatment provides a context for consideration of intestinal infection with less common protozoan pathogens such as Dientamoeba fragilis and Balantidium coli and 'nonpathogenic' protozoa such as Blastocystis hominis and Entamoeba coli.

UR - http://www.scopus.com/inward/record.url?scp=0027486488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027486488&partnerID=8YFLogxK

M3 - Article

C2 - 8254155

AN - SCOPUS:0027486488

VL - 7

SP - 467

EP - 485

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

SN - 0891-5520

IS - 3

ER -